MedTrace Logo

Prognostic Value of the 6-minute Stepper Test in Non-small Cell Lung Cancer Surgery

NCT03824977 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 122

Last updated 2022-03-07

No results posted yet for this study

Summary

The objective of this study is to evaluate the performances of the Six-Minute Stepper Test (6MST) and Sit To Stand test (STST) to predict post-operative complications after minimally invasive lung cancer resection.

Conditions

  • Lung Neoplasm Malignant
  • Resectable Lung Non-Small Cell Carcinoma

Interventions

DIAGNOSTIC_TEST

Six minutes stepper test (6MST)

The 6MST is done using a stepper (Stepper essential, Decathlon(TM), France), with a walking height of 20 cm, placed in front of a wall or parallel bars, so patients can hold on if necessary. Patients are instructed to make the maximum number of steps possible in 6 minutes, and are given a time check at one minute intervals.

DIAGNOSTIC_TEST

Sit to stand test (STST)

The STST is done using a chair measuring 47 cm in height. The patient are instructed to sit in the chair and then to do the maximum number of lifts possible from the chair, in 1 minute, with arms folded and without leaning against the chair.

Sponsors & Collaborators

  • University Hospital, Rouen

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-21
Primary Completion
2020-02-04
Completion
2020-02-04

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03824977 on ClinicalTrials.gov